Hairline International Research and Treatment Center has tied up with Merisis Therapeutics, a division of DiponEd Bio Intelligence LLP, to facilitate genetic testing for their patients in Bangaluru.
Dr Dinesh G Gowda, Dermatosurgeon, Hairline International Research and Treatment Center said, “Anyone with hair and skin condition will now be able to get a medical forecast that will tell them with 80 per cent accuracy their risk of going bald or developing particular skin ailments. This is a big breakthrough in the medical world as we doctors can now prescribe the right course of action to arrest progression of a disease.”
Speaking on the occasion, Bani Anand, Managing Director and Founder, Hairline International Research and Treatment Center said, “Lifestyles today are hectic, and youngsters in the 25-30 years age group are showing symptoms of balding due to genetic predisposition as well as lifestyle. With such genomic profiling, we are able to ascertain accurately whether a person is prone to excessive loss of hair. This will facilitate us in creating a customised treatment plan that ensures the health of hair and stops progression of balding”.
EH News Bureau
